A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
Prolyl hydroxylation domain (PHD) enzymes catalyze the hydroxylation of the transcription factor hypoxia‐inducible factor (HIF) and serve as cellular oxygen sensors. HIF and the PHD enzymes regulate numerous potentially tissue‐protective target genes which can adapt cells to metabolic and ischemic s...
Asıl Yazarlar: | Mayer, M, Fey, K, Heinze, E, Rainer Wick, C, Abboud, M, Yeh, T, Tumber, A, Orth, N, Schley, G, Buchholz, B, Clark, T, Schofield, C, Willam, C, Burzlaff, N |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
Wiley
2018
|
Benzer Materyaller
-
No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
Yazar:: Andrea Hartner, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01) -
Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
Yazar:: Chan, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
Yazar:: Yeh, TL, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
The use of dioxygen by HIF prolyl hydroxylase (PHD1).
Yazar:: McNeill, L, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
Yazar:: Mole, D, ve diğerleri
Baskı/Yayın Bilgisi: (2003)